Skip to Content Skip to Search
bacteria-close-up

What happens if antibiotics stop working?

We’re proud to say that we’re one of the few companies still investing in a new generation of antibiotics. Because antibiotic resistance isn’t a problem of the future, it’s already here.

Doing more in the US

Julia who takes Excedrin for Migraine running through the park

Across the US, we employ more than 15,000 people - from our Vaccines R&D headquarters in Maryland, to our R&D Hub in Pennsylvania, and from one of our nearly 10 manufacturing sites across America, our employees and our values are at the heart of everything we do. This work starts one person, one community, and one story at a time